Alembic Pharma gets final US FDA nod for Carbamazepine tablets

Carbamazepine Tablets USP, 200 mg have an estimated market size of $32 million for 12 months ending December 2024, according to IQVIA.

Leave a Reply

Your email address will not be published. Required fields are marked *